Cancer Research

4 articles

Microscopic view of cancer cells being targeted by a glowing therapeutic agent, representing Revolution Medicines' experimental drug.

Revolution Medicines' Experimental Pancreatic Cancer Drug Shows Promise

Revolution Medicines' experimental drug daraxonrasib doubled the median overall survival for patients with metastatic pancreatic cancer to 13.2 months in its pivotal Phase 3 trial.

David Grossman·May 31, 2026

Scientists in a futuristic lab analyzing holographic data related to bispecific cancer immunotherapies, symbolizing a breakthrough in oncology research.

Cosmos & Space

BioNTech, Pfizer Share Bispecifics Data at ASCO

BioNTech's BNT142 achieved 7 RECIST 1.

Aram Sarkisian·May 31, 2026

A futuristic laboratory setting with a holographic display showcasing positive patient survival data for a new cancer treatment.

Cosmos & Space

Bristol Myers Squibb shows strong multiple myeloma data

In a significant development for multiple myeloma patients, Bristol Myers Squibb's mezigdomide triplet demonstrated a median progression-free survival of 18 months, more than doubling the 8.

David Grossman·May 30, 2026

Microscopic view of gut bacteria and adaptive T cells, illustrating how microbiota influences immune response for tumor control.

Cosmos & Space

Microbiota Induces T Cell Plasticity for Tumor Control

In a groundbreaking study, researchers found that the presence of a specific gut bacterium, Segmented Filamentous Bacteria (SFB), dramatically boosted the anti-tumor effects of PD-1 immunotherapy in m

Marcus Cole·May 18, 2026